With all eyes on drug prices, payers are looking to biosimilar agents to cut costs—and improve patient outcomes.
Pharmacy Best Practices
Two recent studies on antibiotic use may indicate that antibiotic prescribing could be improving over time, but there’s room for improvement. Here’s four takeaways to get even better.
In these arrangements, drug companies must partially reimburse insurers if the drug fails to earn its keep. Will COPD drugs be included in such arrangements?
Despite a scolding from President Trump over drug price hikes, drug giant Pfizer announced it will raise the prices of 41 medications in January. That’s 10% of its entire drug portfolio.
This comprehensive, pay-for-performance approach drives clinical quality and affordability.
Biosimilars hold great cost savings promises for payers and patients alike—but only if prescribers and patients are willing to make the switch.
Healthcare stakeholders can impact a patient’s health by leveraging available capabilities and resources to help achieve better health outcomes and address this opioid epidemic.
Cancer medication spending is unsustainable, but significant savings can be achieved just by reducing waste. Here’s how.
Better care at lower costs is the ultimate goal across healthcare today. Here’s how pharmacists can help.
Specialty pharmaceuticals make up a huge part of the current drug market, and their impact is only going to grow over the next few years.